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Background: Candidemia results in substantial morbidity
and mortality and species distribution and its suscepti-
bility proﬁle should be locally monitored. Antifungigram
still a challenge but few laboratories have microdilution
techniques in Latin America, in a routine basis, and other
methodologies should be evaluated.
Methods: Epidemiological data from candidemia episodes
were collected during 2006 in a large teaching hospital. Inci-
dence was calculated by 1,000 admission and 1,000 patient
days.
Minimal inhibitory concentrations (MIC) were determined
using Sensititre Yeast-One Y8, and E-test. The follow-
ing drugs were tested: amphotericin B (AMB); caspofungin
(CAS); posaconazole (POS), ﬂuconazole (FLU), Itraconazol
(ITRA) and voriconazole (VOR). The disk diffusion method
was also performed for FLU and VOR according to CLSI.
Results: One hundred and thirty-six cases of candidemia
were identiﬁed and represented 3.5% of the overall pos-
itive blood cultures. Incidence was 1.87 cases per 1,000
admissions and 0.27 cases per 1,000 patient-days. 58.1%
patients were male and the median age was 40 years
old being cancer the most frequent associated underlying
disease. C. albicans (52.2%), followed by C. parapsilo-
sis (22.1%), C. tropicalis (14.8%) and C. glabrata (6.6%)
were the more frequent species. Among 100 isolates viable
for susceptibility tests 100% were susceptible to AMB (MIC
90 = 1.0mg/L) and CAS (MIC 90 = 0.064mg/L); 98% to VOR
(MIC 90 = 0.008mg/L); 91% to FLU (MIC90 = 0.5mg/L); and
66% to ITRA (MIC 90 = 0.125mg/L).
Posaconazole MIC90was 0.032mg/mL. The percentage of
essential agreement (EA) and categorical agreement (CA)
between broth micro dilution and other methodologies were
>93%, except for itraconazole (EA 80%, CA 70%). CA between
Sensititre Yeast-One versus disk diffusion and E-test versus
disk diffusion for FLU were respectively: (94%; 95%) and for
VOR(96%,98%). Minor errors accounted for the majority of
categorical errors.
Conclusion: Candidemia by C. albicans still the majority
of episodes in our Hospital but non-albicans C species are
a growing problem and its susceptibility should be closed
monitored even though overall resistance still very low. Disk
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iffusion and E-test had good CA and may be an alternative
ethodology for routine Latin America laboratories.
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revalence of Cryptococcal meningitis among HIV
eropositive patients in Georgia
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Background: Cryptococcal meningitis is a frequently
bserved opportunistic fungal infection in HIV seropositive
atients in Georgia and an important cause of mortality
mong these patients. This study estimates the prevalence
f cryptococcal disease in Georgia in 2003-2008 among
uman immunodeﬁciency virus (HIV)-infected patients who
ere at risk.
Methods: Numerator data were generated by surveying
ll HIV infected patients in Georgia during 2003- 2008 years.
routine serum cryptococcal antigen screening was per-
ormed on 920 HIV-positive/AIDS patients by ELISA (Premier
eridian, Italy) to improve the prognosis of cryptococcal
eningitis in HIV-infected patients through earlier diagno-
is. The cerebrospinal ﬂuid (CSF) samples were processed
or ELISA testing after preliminary microscopic examination,
omprising wet mount, Indian ink.
Results: Cryptococcal antigen was detected in the sera of
03 (11.2%) of them. Cerebrospinal ﬂuid was obtained from
8 of these 103 patients and the presence of Cryptococcus
eoformans was demonstrated by direct microscopy in 64
66%) of them. This represents 7% of the originally screened
IV seropositive group. The incidence of cryptococcal isola-
ion was in the 30-45 age group and predominantly affected
ere male patients (59 from 64).
Conclusion: In Georgia prevalence of Cryptococcal
eningitis among HIV seropositive patients is about 7%.
e found some relationship between age, gender and
revalence of Cryptococcal meningitis among HIV infected
atients. The routine mycological surveillance is required
or HIV/AIDS patients to help in an early diagnosis and appro-
riate therapy.
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linical analysis of 92 patients with Fungaemia - data from
ational survey in Slovakia
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Comenius University, Bratislava, SlovakiaBackground: A prospective national survey on fungaemia
as done during 2005-2007 in Slovakia. The increasing inci-
ence of fungaemia and candidaemia was documented (2.57
nd 2.16/100.000/year, respectively) comparing previous
